|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
FISH, D13S319, Deletion 13q14.3, TC
Test CodeCPT Codes
88271 (x2), 88275<br>Restricted Client Code - Tech Only
Preferred Specimen
Minimum Volume
Other Acceptable Specimens
Instructions
Clinical history/reason for referral is required with test order. Prior therapy and transplant history should be provided with test order.
Submit 1 to 3 mL of bone marrow or 3 to 5 mL whole blood in a sodium heparin (green-top) tube.
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. Do not reject.
Transport Temperature
Specimen Stability
Methodology
Fluorescence in situ Hybridization
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Clinical Significance
This test is performed in addition to G-banding chromosome analysis tests for bone marrow, hematologic blood, or lymph node.
Deletion of chromosome 13q14.3 occurs in multiple myeloma, non Hodgkin?s lymphoma, chronic lymphocytic leukemia, myeloproliferative disorders, myelodysplastic syndrome, and acute myelogenous leukemia. The D13S319 Fluorescence In Situ Hybridization (FISH) probe is useful in detecting deletions in a higher percentage of cells than by routine cytogenetic studies. The probe can be used to evaluate complex karyotypes for loss of this critical gene region.